Sleep expert Dr. Abhay Sharma talks about how Zepbound is now approved by the FDA for the treatment of moderate to severe ...

The global sleep apnea implants market is expected to grow from USD 317.1 million in 2023 to USD 1,158.1 million by 2033, at ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

CR shares expert guidance on the best sleep position, pillows, mattresses, and more if you have sleep apnea, GERD, asthma, ...

Researchers at the University of California, Irvine and New York's Columbia University have embedded transistors in a soft, ...

Awareness of sleep apnea and its relatively common and effective treatment has grown over the past three decades.

Insomnia often causes excessive daytime sleepiness and fatigue. Obstructive sleep apnea (OSA) is when you briefly stop breathing during sleep because the airways of your throat become too narrow ...

On the other hand, intermittent upper airway obstructions in OSAS during sleep would cause hypoxia with subsequent decrease in PaO 2 and increase in PaCO 2. The episodic vascular insufficiency may ...

The Food and Drug Administration (FDA) on Dec. 20 approved the obesity medication Zepbound (tirzepatide) as the first pharmaceutical treatment for moderate-to-severe obstructive sleep apnea (OSA) in ...

The first implant was done in Pittsburgh in Dec 2023 ... recently approved the first drug to treat obstructive sleep apnea. It’s a weight-loss drug called Zepbound (tirzepatide) which ...

Taylor Leamey writes about all things wellness, specializing in mental health, sleep and nutrition coverage. She has invested hundreds of hours into studying and researching sleep and holds a ...